BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 12561066)

  • 1. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins.
    Pan W; Ishii H; Ebihara Y; Gobe G
    J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma.
    Tucci MG; Lucarini G; Giangiacomi M; Zizzi A; Criante P; Ricotti G; Biagini G
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1220-5. PubMed ID: 17062035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 expression as a prognostic factor of survival of gastric carcinoma.
    Inada T; Kikuyama S; Ichikawa A; Igarashi S; Ogata Y
    Anticancer Res; 1998; 18(3B):2003-10. PubMed ID: 9677457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
    Liu J; Ikeguchi M; Nakamura S; Kaibara N
    J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 is an indicator of tumor progression in early but not advanced gastric carcinomas.
    Ishii HH; Gobe GC; Ebihara Y
    Hepatogastroenterology; 2007; 54(79):2159-63. PubMed ID: 18251181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
    Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
    J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes.
    Arun B; Kilic G; Yen C; Foster B; Yardley D; Gaynor R; Ashfaq R
    Cancer; 2003 Dec; 98(12):2554-9. PubMed ID: 14669273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
    Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
    J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
    Frankfurt OS; Robb JA; Sugarbaker EV; Villa L
    Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
    Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
    BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.
    Sierra A; Castellsagué X; Tórtola S; Escobedo A; Lloveras B; Peinado MA; Moreno A; Fabra A
    Clin Cancer Res; 1996 Nov; 2(11):1887-94. PubMed ID: 9816145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of apoptosis-related factors in lining epithelium of radicular cysts.
    Suzuki T; Kumamoto H; Kunimori K; Ooya K
    J Oral Pathol Med; 2005 Jan; 34(1):46-52. PubMed ID: 15610406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population.
    Triantafyllou K; Kitsanta P; Karamanolis DG; Kittas C; Ladas SD
    Dig Liver Dis; 2008 Jan; 40(1):39-45. PubMed ID: 18063429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
    Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y
    Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery.
    Zhu Y; Zhou XY; Yao XD; Dai B; Ye DW
    BJU Int; 2007 Jul; 100(1):204-8. PubMed ID: 17433031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer.
    Bani-Hani KE; Almasri NM; Khader YS; Sheyab FM; Karam HN
    Clin Cancer Res; 2005 Feb; 11(4):1447-53. PubMed ID: 15746045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.